These increases of IL-23, MIP-2 and GATA3 were significantly declined in rMS-Ag85a-IL-17a vaccinated group; however, the administration of rMS-Ag85a-IL-17a did not affect RORγt expression in severe asthma. This evidence concerns the gene IL17A and asthma.